1. Dr. Bhagbanprakash
National AIDS Control Organization
Feedback Received from
Partners

2. 2
Feedback received from partners
 WHO (WR)
 BILL & MELINDA GATES FOUNDATION
 INP+
 CIDA
 WORLD BANK
 DFID
 IAVI
 EUROPEAN UNION

3. 3
Feedback awaited from
 UNDP
 UNICEF
 UNODC
 UNFPA
 UNIFEM
 ILO
 UNESCO
 WFP

4. 4
Feedback awaited from
 UNHCR
 USAID
 CDC
 AusAID
 SIDA
 EMBASSY OF FDR GERMANY
 ROYAL NORWEGIAN EMBASSY
 ROYAL NETHERLANDS EMBASSY

5. 5
Feedback awaited from
 ROYAL NORWEGIAN EMBASSY
 ROYAL NETHERLANDS
EMBASSY
 JICA
 DANIDA

6. 6
Partner inputs on key issues
(Summary)
Identify and resolve major institutional
and capacity issues hindering the scaling
up and implementation of the NACP.
Effective involvement of different sectors
in promoting NACP.
Engage UN Theme Group members in
programme design; organize regular
bilateral consultations.

7. 7
Partner inputs on key issues
(Summary)
Promote decentralization, strengthen
stewardship roles of NACO and SACS.
Generate commitment among different
states, stakeholders.
Extend NACP focus on rural areas:
integrated geographically focussed
programme models.

8. 8
Partner inputs on key issues
(Summary)
Engage UN Theme Group members in
programme design; organize regular
bilateral consultations.
Promote decentralization, strengthen
stewardship roles of NACO and SACS.
Generate commitment among different
states, stakeholders.

9. 9
Partner inputs on key issues
(Summary)
Extend NACP focus on rural areas: integrated
geographically focussed programme models.
Focus on HIV prevention among high-risk
behaviour groups, especially female sex workers
and their clients.
Empower SACS and their implementing
partners.
Engender NACP-III implementation.

10. 10
Partner inputs on key issues
(Summary)
Service delivery:
 Create a model package of services for
key populations and bring that suite of
services to scale through a variety of
partners.
 Provide treatment and care in a phased,
well-planned and sustainable manner.

11. 11
Partner inputs on key issues
(Summary)
Include AIDS vaccine as an integral
component of preventive strategies.
Increased coordination between AIDS
vaccine development and sentinel
surveillance, VCTC, care and treatment
services.
Ensure access to affordable drugs/TRIPS
PLUS issue

12. 12
Partner inputs on key issues
(Summary)
Advocacy & Research
 Strengthen advocacy efforts.
 Ensure M & E system is negotiated
with key constituencies in the country.

13. 13
Partner inputs on key issues
(Summary)
GIPA
 National GIPA strategy, involving PLWHA
and affected communities at the NACO
and SACS levels.
 Involve PLWHA, and marginalized
communities, use their experiences in
NACP-III planning.

14. 14
Partner inputs on key issues
(Summary)
GIPA
 Specific budget allocations for national, state
and district level PLWHA networks.
 Concrete steps to decrease stigma and
discrimination.
 Treatment education for PLWHA.
 Positive prevention through safer sex and safer
injecting practices.

15. 15
Role/Contribution towards NACP – III
as envisaged by partners
WHO-WR:
 Provide technical guidance and advice in
care and treatment, ART, VCT, M & E,
Training.
 Projection of HIV/AIDS situation in India.
 Technical and managerial support to
NACO.

16. 16
Partner role/contribution towards
NACP – III Contd.
World Bank
 Resource support for studies and
workshops
 Support to GOI’s new National HIV/AIDS
Strategic Plan.
 Finance NACP-III activities other partners
cannot finance.

17. 17
Partner role/contribution towards
NACP – III Contd.
DFID
 To pool funds along with other donors
for implementation of NACP-III.
 Fund studies to inform the
preparatory processes of NACP – III.

18. 18
Partner role/contribution towards
NACP – III Contd.
European Union
 Would fund research/studies on issues
proposed by/agreed with NACO &
supported by UN Theme Group.
 Continue financial support to GFATM,
IAVI other regional and global initiatives &
NGOs.

19. 19
Partner role/contribution towards
NACP – III Contd.
Bill & Melinda Gates Foundation
 Will commit $200 million over five years to
focused HIV/AIDS prevention efforts.
 Will concentrate on the 6 highest
prevalent states and national highways.

20. 20
Partner role/contribution towards
NACP – III Contd.
Bill & Melinda Gates Foundation
 Support initiatives in capacity building,
communications, research and impact
measurement.
 Creation of enabling environment,
galvanizing political and societal leaders.

21. 21
Partner role/contribution towards
NACP – III Contd.
INP+
 Work closely with NACO and SACS.
 Support advocacy,and service delivery.
 Giving a human voice and face to the
epidemic for people not directly touched
by it.

22. 22
Partner role/contribution towards
NACP – III Contd.
INP+
 Giving a human voice and face to the
epidemic for people not directly touched
by it.
 Running care models and building
networks.

23. 23
Partner role/contribution towards
NACP – III Contd.
IAVI
 Facilitate efforts for preparation of a
national AIDS vaccine development plan.
 Provide technical expertise on AIDS
vaccine and clinical trials.

24. 24
IAVI
 Facilitate epidemiological studies in
partnership with SACS.
 Share and help implement international
best practices related to vaccine, R&D
activities.

25. THANK YOU